Immunocytochemical detection of p53 protein from pancreatic duct brushings in patients with pancreatic carcinoma

Cancer

Volumn 77, Issue 11, 1996, Pages 2233-2239

  Ishimaru, Shouhei ^a   Itoh, Masaki ^a   Hanada, Keiji ^a   Tsuchida, Akira ^a   Iwao, Toshiyasu ^a   Kajiyama, Goro ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

chronic pancreatitis; cytology; immunocytochemistry; p53 protein; pancreatic carcinoma; pancreatic duct brushing

Indexed keywords

IODINATED CONTRAST MEDIUM; MONOCLONAL ANTIBODY; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; MALE; PANCREAS CARCINOMA; PANCREAS DUCT; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; ANIMALS; CELL LINE; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHRONIC DISEASE; COLORING AGENTS; CONSTRICTION, PATHOLOGIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROBLASTS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; NEOPLASM PROTEINS; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PANCREATITIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029999752     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960601)77:11<2233::AID-CNCR8>3.0.CO;2-Q     Document Type: Article

References (25)

1. Niederau C, Grendell JH. Diagnosis of pancreatic carcinoma. Imaging techniques and tumor markers. Pancreas 1992;7: 66-86.
2. Shemesh E, Czerniak A, Nass S, Klein E. Role of endoscopic retrograde cholangiopancreatography in differentiating pancreatic cancer coexisting with chronic pancreatitis. Cancer 1990;65:893-6.
3. Venu RP, Geenen JE, Kini M, Hogan WJ, Payne M, Johnson K, et al. Endoscopic retrograde brush cytology: A new technique. Gastroenterology 1990;99:1475-9.
4. Goodale RL, Gajl-Peczalaka K, Dressel T, Samuelson J. Cytologie studies for the diagnosis of pancreatic cancer. Cancer 1981;47:1652-5.
5. Nakaizumi A, Tatsuta M, Uehara H, Yamamoto R, Takenaka A, Kishigami Y, et al. Cytologic examination of pure pancreatic juice in the diagnosis of pancreatic carcinoma. Cancer 1992;70:2610-4.
6. Masumoto S, Harada H, Tanaka J, Ochi K, Seno T, Tsurumi T, et al. Evaluation of cytology and tumor markers of pure pancreatic juice for the diagnosis of pancreatic cancer at early stages. Pancreas 1994;9:741-7.
7. Kameya S, Kuno N, Kasugai T. The diagnosis of pancreatic cancer by pancreatic juice cytology. Acta Cytol 1981;25:354-60.
8. Shimizu T. Clinical study of endoscopic brushing cytology of the pancreatic duct. Gastrointest Endosc 1992;34:2817-26.
9. Michael ER. Cytologic brushings of ductal lesions during ERCP. Gastrointest Endosc 1991;37:139-42.
10. Scarpa A, Tatsuta M, Mukai K, Zamboni G, Oda T, Iacono C, et al. Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol 1993;142:1534-43.
11. Redston MS, Caldas C, Seymour AB, Hruban RH, Costa L, Yeo CJ, et al. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res 1994;54:3025-33.
12. Suzuki T, Takano Y. Comparative immunohistochemical studies of p53 and proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions in pancreatic duct cell carcinomas. Jpn J Cancer Res 1993;84:1072-7.
13. Pellegata NS, Sessa F, Rnanault B, Bonato M, Leone BE, Solcia E, et al. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 1994;54:1556-60.
14. van Es JM, Polak MM, van den Berg FM, Ramsoekh TB, Graanen ME, Hrubn RH, et al. Molecular markers for diagnostic cytology of neoplasms in head region of the pancreas: mutation of K-ras and overexpression of the p53 protein product. J Clin Pathol 1995;48:218-22.
15. Casey G, Yamanaka Y, Friess H, Kobrin MS, Lopez ME, Buchler M, et al. p53 mutations are common in pancreatic cancer and absent in chronic pancreatitis. Cancer Lett 1993;69:151-60.
16. Barton CM, Staddon SL, Hughes CM, Hall PA, O'Sullivan C, Klöppel G, et al. Abnormalities of the p53 tumor suppressor gene in human pancreatic cancer. Br J Cancer 1991;64:1076-82.
17. Dowell SP, Lane DP, Hall PA. The immunocytochemical detection of p53 protein in cytological specimens: technical considerations. Cytopathology 1994;5:76-81.
18. Cubilla AL, Fitzgerald PJ. Tumors of the exocrine pancreas. Atlas of Tumor Pathology, Second Series, Fascicle 19. Washington DC, Armed Forces Institute of Pathology, 1984.
19. Tada M, Omata M, Kawai S, Saisho H, Ohto M, Saiki RK, et al. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 1993;53:2472-4.
20. Tada M, Omata M, Ohto M. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma. Gastroenterology 1991;100:233-8.
21. Kondo H, Sugano K, Fukayama N, Kyogoku A, Nose H, Shimada K, et al. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma. Cancer 1994;73:1589-94.
22. Laethem JLV, Vertongen P, Deviere J, Rampelbergh JV, Rickaert F, Cremer M, et al. Detection of c-Ki-ras codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumors. Gut 1995;36:781-7.
23. Yanagisawa A, Ohtake K, Ohashi K, Hori M, Kitagawa T, Sugano K, et al. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 1993;53:953-6.
24. Bartek J, Iggo R, Cannon J, Lane DP. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 1990;5:893-9.
25. Dowell SP, Wilson POG, Derias NW, Lane DP, Hall PA. Clinical utility of the immunocytochemical detection of p53 protein in cytological specimens. Cancer Res 1994;54:2914-8.